Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 3 (2006), Issue 1 (January)

1. Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder.
   Prog Neuropsychopharmacol Biol Psychiatry, 30(1): 147-50. [Abstract] [Full-text]
2. Explicit and implicit facial affect recognition in manic and depressed States of bipolar disorder: a functional magnetic resonance imaging study.
   Biol Psychiatry, 59(1): 31-9. [Abstract] [Full-text]
3. Sleeping in? The impact of age and depressive sub-type on hypersomnia.
   J Affect Disord, 90(1): 73-6. [Abstract] [Full-text]
4. Voluntary vs. involuntary hospital admission in acute mania of bipolar disorder: Results from the Swiss sample of the EMBLEM study.
   J Affect Disord, 90(1): 57-61. [Abstract] [Full-text]
5. Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study.
   Br J Psychiatry, 188: 46-50. [Abstract] [Full-text]
6. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK.
   Br J Psychiatry, 188: 21-5. [Abstract] [Full-text]
7. An unusual case of subterfuge in the emergency department: covert administration of antipsychotic and anxiolytic medications to control an agitated patient.
   Ann Emerg Med, 47(1): 75-8. [Abstract] [Full-text]
8. Association of the putative susceptibility gene, transient receptor potential protein melastatin type 2, with bipolar disorder.
   Am J Med Genet B Neuropsychiatr Genet, 141(1): 36-43. [Abstract] [Full-text]
9. Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia.
   Am J Med Genet B Neuropsychiatr Genet, 141(1): 102-9. [Abstract] [Full-text]
10. Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure.
    Am J Med Genet B Neuropsychiatr Genet, 141(1): 76-83. [Abstract] [Full-text]
11. Expression and genetic variability of PCDH11Y, a gene specific to Homo sapiens and candidate for susceptibility to psychiatric disorders.
    Am J Med Genet B Neuropsychiatr Genet, 141(1): 67-70. [Abstract] [Full-text]
12. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
    Arch Pediatr Adolesc Med, 160(1): 65-9. [Abstract] [Full-text]
13. A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder.
    Int J Neuropsychopharmacol, 9(1): 13-20. [Abstract] [Full-text]
14. A possible association between the [minus sign]116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder.
    Int J Neuropsychopharmacol, 9(1): 83-8. [Abstract] [Full-text]
15. Possible interaction between lopinavir/ritonavir and valproic Acid exacerbates bipolar disorder.
    Ann Pharmacother, 40(1): 147-50. [Abstract] [Full-text]
16. Modeling depression: social dominance-submission gene expression patterns in rat neocortex.
    Neuroscience, 137(1): 37-49. [Abstract] [Full-text]
17. Molecular targets versus models for new antiepileptic drug discovery.
    Epilepsy Res, 68(1): 22-8. [Abstract] [Full-text]
18. Brief reports: patterns of psychotropic medication use by race among veterans with bipolar disorder.
    Psychiatr Serv, 57(1): 123-6. [Abstract] [Full-text]
19. Self-reported medication treatment adherence among veterans with bipolar disorder.
    Psychiatr Serv, 57(1): 56-62. [Abstract] [Full-text]
20. Early symptoms of mania and the role of parental risk.
    Bipolar Disord, 7(6): 623-34. [Abstract] [Full-text]
21. Family environment in families with versus families without parental bipolar disorder: a preliminary comparison study.
    Bipolar Disord, 7(6): 617-22. [Abstract] [Full-text]
22. Are the arginine vasopressin V1a receptor microsatellites related to hypersexuality in children with a prepubertal and early adolescent bipolar disorder phenotype?
    Bipolar Disord, 7(6): 610-6. [Abstract] [Full-text]
23. Family, twin, adoption, and molecular genetic studies of juvenile bipolar disorder.
    Bipolar Disord, 7(6): 598-609. [Abstract] [Full-text]
24. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder.
    Bipolar Disord, 7(6): 589-97. [Abstract] [Full-text]
25. Comorbid ADHD is associated with altered patterns of neuronal activation in adolescents with bipolar disorder performing a simple attention task.
    Bipolar Disord, 7(6): 577-88. [Abstract] [Full-text]
26. Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder.
    Bipolar Disord, 7(6): 570-6. [Abstract] [Full-text]
27. Cortical gray matter differences identified by structural magnetic resonance imaging in pediatric bipolar disorder.
    Bipolar Disord, 7(6): 555-69. [Abstract] [Full-text]
28. Declarative memory impairment in pediatric bipolar disorder.
    Bipolar Disord, 7(6): 546-54. [Abstract] [Full-text]
29. Using affect-modulated startle to study phenotypes of pediatric bipolar disorder.
    Bipolar Disord, 7(6): 536-45. [Abstract] [Full-text]
30. History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk.
    Bipolar Disord, 7(6): 525-35. [Abstract] [Full-text]
31. The CBCL predicts DSM bipolar disorder in children: a receiver operating characteristic curve analysis.
    Bipolar Disord, 7(6): 518-24. [Abstract] [Full-text]
32. Comparing diagnostic checklists for pediatric bipolar disorder in academic and community mental health settings.
    Bipolar Disord, 7(6): 507-17. [Abstract] [Full-text]
33. Bipolar disorder in children and adolescents: international perspective on epidemiology and phenomenology.
    Bipolar Disord, 7(6): 497-506. [Abstract] [Full-text]
34. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents.
    Bipolar Disord, 7(6): 483-96. [Abstract] [Full-text]
35. Bipolar disorder and quality of life: a patient-centered perspective.
    Qual Life Res, 15(1): 25-37. [Abstract] [Full-text]
36. Ethnic differences in symptom presentation of youths with bipolar disorder.
    Bipolar Disord, 8(1): 95-9. [Abstract] [Full-text]
37. Phenomenology associated with age at onset in patients with bipolar disorder at their first psychiatric hospitalization.
    Bipolar Disord, 8(1): 91-4. [Abstract] [Full-text]
38. Neuropsychological impairment in bipolar disorder: the relationship with glucocorticoid receptor function.
    Bipolar Disord, 8(1): 85-90. [Abstract] [Full-text]
39. Stability of estimated IQ across mood state in patients with bipolar disorder.
    Bipolar Disord, 8(1): 81-4. [Abstract] [Full-text]
40. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Bipolar Disord, 8(1): 75-80. [Abstract] [Full-text]
41. Regional cerebral cortical thinning in bipolar disorder.
    Bipolar Disord, 8(1): 65-74. [Abstract] [Full-text]
42. Diagnostic subtypes of bipolar disorder in older versus younger adults.
    Bipolar Disord, 8(1): 56-64. [Abstract] [Full-text]
43. Fronto-temporal function may distinguish bipolar disorder from schizophrenia.
    Bipolar Disord, 8(1): 47-55. [Abstract] [Full-text]
44. Neurocognitive impairment in euthymic young adults with bipolar spectrum disorder and recurrent major depressive disorder.
    Bipolar Disord, 8(1): 40-6. [Abstract] [Full-text]
45. Stroop performance in bipolar disorder: further evidence for abnormalities in the ventral prefrontal cortex.
    Bipolar Disord, 8(1): 28-39. [Abstract] [Full-text]
46. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders.
    Bipolar Disord, 8(1): 1-14. [Abstract] [Full-text]
47. Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?
    J Neural Transm, 113(2): 255-68. [Abstract] [Full-text]
48. A blessing in disguise: Resolution of tardive dyskinesia with development of cervical myelitis.
    Mov Disord, 21(1): 120-2. [Abstract] [Full-text]
49. Sources of declarative memory impairment in bipolar disorder: mnemonic processes and clinical features.
    J Psychiatr Res, 40(1): 47-58. [Abstract] [Full-text]
50. Impaired recruitment of the dorsolateral prefrontal cortex and hippocampus during encoding in bipolar disorder.
    Biol Psychiatry, 59(2): 138-46. [Abstract] [Full-text]
51. Community pharmacy services to optimise the use of medications for mental illness: a systematic review.
    Aust New Zealand Health Policy, 2: 29. [Abstract] [Full-text]
52. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.
    J Psychiatr Res, 40(1): 81-8. [Abstract] [Full-text]
53. Hyperprolinemia is not associated with childhood onset schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet, 141(2): 192. [Abstract] [Full-text]
54. Fine mapping of a susceptibility locus for bipolar and genetically related unipolar affective disorders, to a region containing the C21ORF29 and TRPM2 genes on chromosome 21q22.3.
    Mol Psychiatry, 11(2): 134-42. [Abstract] [Full-text]
55. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples.
    Mol Psychiatry, 11(2): 125-33, 115. [Abstract] [Full-text]
56. Topiramate for acute affective episodes in bipolar disorder.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
57. The interaction between TPH2 promoter haplotypes and clinical-demographic risk factors in suicide victims with major psychoses.
    Genes Brain Behav, 5(1): 107-10. [Abstract] [Full-text]
58. Molecular genetics of bipolar disorder.
    Genes Brain Behav, 5(1): 85-95. [Abstract] [Full-text]
59. Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder.
    Neurosci Lett, 394(3): 243-5. [Abstract] [Full-text]
60. The Wnt-dependent signaling pathways as target in oncology drug discovery.
    Invest New Drugs. [Abstract] [Full-text]
61. Tyrosine hydroxylase gene regulation in human neuronal progenitor cells does not depend on Nurr1 as in the murine and rat systems.
    J Cell Physiol, 207(1): 49-57. [Abstract] [Full-text]
62. The interaction between dopamine D-like and beta-adrenergic receptors in the prefrontal cortex is altered by mood-stabilizing agents.
    J Neurochem. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.